Inhibition of Vascular Smooth Muscle and Cancer Cell Proliferation by New VEGFR Inhibitors and Their Immunomodulator Effect: Design, Synthesis, and Biological Evaluation

<div>The essential pharmacophoric features of VEGFR-2 inhibitors. Red: hinge head; green: linker; blue: hydrogen-bonding moiety; maroon: hydrophobic tail.</div>

Oxidative Medicine and Cellular Longevity

fig1

Figure 1

Figure 1: Inhibition of Vascular Smooth Muscle and Cancer Cell Proliferation by New VEGFR Inhibitors and Their Immunomodulator Effect: Design, Synthesis, and Biological Evaluation 

Figure 1 | Inhibition of Vascular Smooth Muscle and Cancer Cell Proliferation by New VEGFR Inhibitors and Their Immunomodulator Effect: Design, Synthesis, and Biological Evaluation 